Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism.
Author
Jayasena, Channa NAnderson, Richard A
Llahana, Sofia
Barth, Julian H
MacKenzie, Finlay
Wilkes, Scott
Smith, Neil
Sooriakumaran, Prasanna
Minhas, Sukhbinder
Wu, Frederick C W
Tomlinson, Jeremy
Quinton, Richard
Publication date
2021-11-22
Metadata
Show full item recordAbstract
Male hypogonadism (MH) is a common endocrine disorder. However, uncertainties and variations in its diagnosis and management exist. There are several current guidelines on testosterone replacement therapy that have been driven predominantly by single disciplines. The Society for Endocrinology commissioned this new guideline to provide all care providers with a multidisciplinary approach to treating patients with MH. This guideline has been compiled using expertise from endocrine (medical and nursing), primary care, clinical biochemistry, urology and reproductive medicine practices. These guidelines also provide a patient perspective to help clinicians best manage MH.Citation
Jayasena CN, Anderson RA, Llahana S, Barth JH, MacKenzie F, Wilkes S, Smith N, Sooriakumaran P, Minhas S, Wu FCW, Tomlinson J, Quinton R. Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism. Clin Endocrinol (Oxf). 2022 Feb;96(2):200-219. doi: 10.1111/cen.14633. Epub 2021 Nov 22Type
ArticlePMID
34811785Journal
Clinical EndocrinologyPublisher
Wileyae974a485f413a2113503eed53cd6c53
10.1111/cen.14633